foxo4-dri senolytic peptide research The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI - 10mg (Proxofim) -
FOXO4 DRI 10mg (Proxofim) River Peptides Ltd Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC FOXO4 DRI Peptide for Cellular Senescence and Anti Aging Research Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine Buy FOXO4 DRI Peptide (Proxofim) 10mg BiotechPeptides
Pay in 4 interest-free payments of $5.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22




